Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, Kam BLR, Lobbes MBI, de Boer M, Verhoef C, Sars PRA, Heijmans HJ, van Haaren ERM, Vles WJ, Contant CME, Menke-Pluijmers MBE, Smit LHM, Kelder W, Boskamp M, Koppert LB, Luiten EJT, Smidt ML. Simons JM, et al. Among authors: van klaveren d, van nijnatten tja, van der pol cc, van diest pj, van haaren erm. JAMA Surg. 2022 Nov 1;157(11):991-999. doi: 10.1001/jamasurg.2022.3907. JAMA Surg. 2022. PMID: 36069889 Free PMC article.
Performance metrics for models designed to predict treatment effect.
Maas CCHM, Kent DM, Hughes MC, Dekker R, Lingsma HF, van Klaveren D. Maas CCHM, et al. Among authors: van klaveren d. BMC Med Res Methodol. 2023 Jul 8;23(1):165. doi: 10.1186/s12874-023-01974-w. BMC Med Res Methodol. 2023. PMID: 37422647 Free PMC article.
A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
van Nijnatten TJA, Simons JM, Smidt ML, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, Kam BLR, Lobbes MBI, de Boer M, Verhoef K, Koppert LB, Luiten EJT. van Nijnatten TJA, et al. Among authors: van klaveren d, van der pol cc, van diest pj. Clin Breast Cancer. 2017 Aug;17(5):399-402. doi: 10.1016/j.clbc.2017.04.006. Epub 2017 Apr 19. Clin Breast Cancer. 2017. PMID: 28487053
Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
Verver D, van Klaveren D, Franke V, van Akkooi ACJ, Rutkowski P, Keilholz U, Eggermont AMM, Nijsten T, Grünhagen DJ, Verhoef C. Verver D, et al. Among authors: van klaveren d, van akkooi acj. Br J Surg. 2019 Feb;106(3):217-225. doi: 10.1002/bjs.10995. Epub 2018 Oct 11. Br J Surg. 2019. PMID: 30307046 Free PMC article.
Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery.
Shapiro J, van Klaveren D, Lagarde SM, Toxopeus EL, van der Gaast A, Hulshof MC, Wijnhoven BP, van Berge Henegouwen MI, Steyerberg EW, van Lanschot JJ. Shapiro J, et al. Among authors: van klaveren d, van lanschot jj, van der gaast a, van berge henegouwen mi. Br J Surg. 2016 Jul;103(8):1039-47. doi: 10.1002/bjs.10142. Epub 2016 Apr 26. Br J Surg. 2016. PMID: 27115731
Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer.
Shapiro J, Biermann K, van Klaveren D, Offerhaus GJ, Ten Kate FJ, Meijer SL, van Berge Henegouwen MI, Steyerberg EW, Wijnhoven BP, Lanschot JJ. Shapiro J, et al. Among authors: van klaveren d, van berge henegouwen mi. Ann Surg. 2017 Feb;265(2):356-362. doi: 10.1097/SLA.0000000000001630. Ann Surg. 2017. PMID: 28059964
Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy.
Noordman BJ, van Klaveren D, van Berge Henegouwen MI, Wijnhoven BPL, Gisbertz SS, Lagarde SM, van der Gaast A, Hulshof MCCM, Biermann K, Steyerberg EW, van Lanschot JJB; also on behalf of the CROSS-study group. Noordman BJ, et al. Among authors: van klaveren d, van berge henegouwen mi, van der gaast a, van lanschot jjb. Ann Surg. 2018 May;267(5):892-897. doi: 10.1097/SLA.0000000000002240. Ann Surg. 2018. PMID: 28350565 Clinical Trial.
Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool.
van den Hoven I, van Klaveren D, Verheuvel NC, van la Parra RFD, Voogd AC, de Roos WK, Bosscha K, Heuts EM, Tjan-Heijnen VCG, Roumen RMH, Steyerberg EW. van den Hoven I, et al. Among authors: van klaveren d, van la parra rfd. J Surg Oncol. 2019 Sep;120(4):578-586. doi: 10.1002/jso.25644. Epub 2019 Jul 23. J Surg Oncol. 2019. PMID: 31338839 Free PMC article.
136 results